The Health Secretary, Andrew Lansley has declared the Governments’ decision for the allotment of £50m to the emergency fund from next October. This fund, he says, will be increased to £200m a year, from next April.

This emergency cancer fund is aimed at increasing the access to pricey life-prolonging treatments for the patients. But, this can be done best, only if the drug manufacturers cut down on the prices.

Cancer treatment is one of the most expensive treatments costing tens of thousands of Pounds to one patient. And therefore, this fund will ensure better quality of living for patients by paying for their medicines. However, this continues to be doubtful, as there is a probability that the National Institute for Clinical Excellence might reject the same for being so expensive.

The Lancet editorial said, "Presumably, emergency funds for dementia and multiple sclerosis drugs will be announced in due course – anything else would be intellectually indefensible”.

However, the Government must also make sure that the funds do not get exhausted and for that it will need to keep a control on the entire cost spent in order to make new treatments available.

According to the sources, the cost would raise to £330m a year, if all the required treatments were made available to the physicians for the patients.